The USFDA approved female Viagra known as Addyi came as a hope to many women who suffer from low sex drive. As the pill brought with it hope to improve their sex life and equation with their partners. However for women in India the wait is still not over yet. Although patented as Flibanserin and marketed by Sprout Pharmaceuticals is to hit the market soon globally it is expected to reach the Indian markets after at least three or four years. Social unacceptance prolong trial period as cited as some factors by experts that could delay the launch in India.